AI assistant
Indoco Remedies Ltd. — Call Transcript 2023
May 15, 2023
62453_rns_2023-05-15_4a364f6b-5730-4703-a3a9-a696e118722c.pdf
Call Transcript
Open in viewerOpens in your device viewer
==> picture [199 x 70] intentionally omitted <==
May 15, 2023
| To | To |
|---|---|
| The Listing Department | The Listing Department |
| National Stock Exchange of India Limited | Bombay Stock Exchange Limited |
| Exchange Plaza, | Floor 25, P. J. Towers, |
| Bandra – Kurla Complex | Dalal Street, |
| Bandra (East) | Mumbai–400 001 |
| Mumbai–400 051 | Stock Code : 532612 |
| Stock Code : INDOCO-EQ |
Dear Sir/Madam,
Sub: Intimation of Earnings Conference Call on Audited Financial Results for fourth quarter and year ended 31[st] March, 2023
Pursuant to Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that an Earnings Conference Call on Audited Financial Results for the fourth quarter and year ended 31[st] March, 2023 is scheduled to be held on Tuesday, 23[rd] May, 2023 at 03:30 P.M. IST.
The details of the conference call are enclosed herewith.
This is for your information and dissemination on respective websites.
Thanking you, Yours faithfully, For Indoco Remedies Limited
RAMANATHA Digitally signed by RAMANATHAN HARIHARAN N HARIHARAN Date: 2023.05.15 13:52:40 +05'30' Ramanathan Hariharan Company Secretary & Legal Head
==> picture [593 x 142] intentionally omitted <==
JM Financial Institutional Securities invites you to the
==> picture [106 x 25] intentionally omitted <==
==> picture [85 x 10] intentionally omitted <==
----- Start of picture text -----
CORPORATE ACCESS
----- End of picture text -----
==> picture [130 x 43] intentionally omitted <==
4QFY 2022-23 earnings conference call with
Indoco Remedies Limited
on Tuesday, 23 May 2023
03:30 PM IST | 06:00 AM USA EDT | 11:00 AM UK TIME | 06:00 PM HK/SINGAPORE TIME
Company Participants
Ms. Aditi Kare Panandikar
Managing Director
Mr. Sundeep V Bambolkar
Jt. Managing Director
Mr. Pramod Ghorpade
Chief Financial Officer
Universal Dialin:
+91-22-6280 1366 / +91-22-7115 8267
Toll Free Number – International UK:
USA: UK: Singapore: Hong Kong: 1 866 746 2133 0 808 101 1573 800 101 2045 800 964 448 Please dial-in 10 minutes prior to the conference schedule to ensure that you are connected in time
Diamond Pass Link:
==> picture [188 x 39] intentionally omitted <==
For further information, please contact
Ms. Cyndrella Carvalho | +91-22-6630 3056 | [email protected] Mr. Jainil Shah | +91-22-6630 3155 | [email protected] Ms. Ninie Singh | +91-22-6630 3481 | [email protected] Ms. Lorraine Gomes | +91-22-6630 3076 | [email protected]
JM Financial Institutional Securities Limited
Corporate Identity Number: U67100MH2017PLC296081
Member of BSE Ltd., National Stock Exchange of India Ltd. and Metropolitan Stock Exchange of India Ltd. SEBI Registration Nos.: – Stock Broker - INZ000163434, Research Analyst – INH000000610 Registered Office: 7th Floor, Cnergy, Appasaheb Marathe Marg, Prabhadevi, Mumbai 400 025, India. Board: +91-22-6630 3030 | Fax: +91-22-6630 3488 | Email: [email protected] | www.jmfl.com Compliance Officer: Mr. Sunny Shah | Tel: +91-22-6630 3383 | Email: [email protected]
Safe harbor:
The proposed management discussion and comments thereof may include forward-looking statements. Forward-looking statements are statements that concern plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements that are other than statements of historical fact. All forward looking statements are subject to risks, uncertainties and assumptions that could cause actual results of operations and financial conditions to differ materially from those contemplated by the relevant statement. All Conference Call Participants should not place undue reliance on these forward-looking statements
- means the place/city is observing daylight saving time (DST) at time shown